16
Participants
Start Date
August 25, 2022
Primary Completion Date
November 12, 2024
Study Completion Date
November 12, 2024
SAR439459
Powder for solution for infusion; IV infusion
Placebo
Solution for infusion; IV infusion
Westmead Hospital_Site Number :0360003, Westmead
Department of Medicine/ School of Clinical Sciences at Monash Health Monash University_246 Clayton Road_Site Number :0360002, Clayton
Kennedy Krieger Institute_Site number 8400004, Baltimore
Vanderbilt University Site Number : 8400011, Nashville
Cincinnati Children's Hospital Medical Center Site Number : 8400010, Cincinnati
Indiana University School of Medicine_Site Number: 8400002, Indianapolis
Hopital Edouard Herriot _Site Number :2500002, Lyon
Hopital Lariboisiere_Site Number :2500001, Paris
Baylor College of Medicine - Site Number:8400003, Houston
UCLA Health_Site Number: 8400006, Los Angeles
Yale University - Site Number:8400007, New Haven
Bone Research and Education Centre_Site Number :1240003, Oakville
Toronto general Hospital_Site Number :1240002, Toronto
Lead Sponsor
Sanofi
INDUSTRY